Outpatient utilization of angiotensin-converting enzyme inhibitors among heart failure patients after hospital discharge

This publication has 19 references indexed in Scilit:

• Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: the CHARM-Preserved Trial
  The Lancet, 2003
• The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood PressureThe JNC 7 Report
  JAMA, 2003
• “Systolic and diastolic dysfunction” in heart failure? Time for a new paradigm
  Journal of Cardiac Failure, 2003
• ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure)
  Circulation, 2001
• Quality of Medical Care Delivered to Medicare Beneficiaries
  JAMA, 2000
• Diabetes guidelines: A summary and comparison of the recommendations of the american diabetes association, veterans health administration, and american association of clinical endocrinologists
  Clinical Therapeutics, 2000
• Effects of an Angiotensin-Converting–Enzyme Inhibitor, Ramipril, on Cardiovascular Events in High-Risk Patients
  New England Journal of Medicine, 2000
• National Patterns of Angiotensin-Converting Enzyme Inhibitor Use in Congestive Heart Failure
  Archives of internal medicine (1960), 1997
• Patterns of angiotensin-converting enzyme inhibitor use in congestive heart failure in two community hospitals
  The American Journal of Cardiology, 1996
• Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure
  JAMA, 1995